See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2014_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 20,809,506 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,528,551 |
| 2 | PropertyPlantAndEquipmentNet | 80,385 |
| 3 | remainder_Assets | 167,479 |
| 4 | LiabilitiesCurrent | 4,937,045 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 646,734 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 35,940,123 |
| 9 | ResearchAndDevelopmentExpense | 35,424,823 |
| 10 | remainder_Expenses | 13,321,162 |
| 11 | remainder_Revenues | 1,863,343 |
| 12 | remainder_NetIncome | 15,278,396 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 23,585,921 |
| 1 | Liabilities | 5,583,779 |
| 2 | Expenses | 84,686,108 |
| 3 | Revenues | 1,863,343 |
| 4 | StockholdersEquity | 18,002,142 |
| 5 | NetIncome | -67,544,369 |
| 6 | ComprehensiveNetIncome | -67,544,369 |
| 7 | BaseVar | 65,498,774 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.94 |
| 9 | EconomicCapitalRatio | 1.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
